BELLEVUE HEALTHCARE TRUST
PLC (the "Company")
LEGAL ENTITY IDENTIFIER ('LEI'):
213800HQ3J3H9YF2UI82
29 November 2024
REDEMPTION
PRICE AND TOTAL VOTING RIGHTS
The Company operates a voluntary redemption
facility through which shareholders may request the redemption of
all or part of their holding of ordinary redeemable shares
("Ordinary Shares") on an annual basis (the "Redemption Facility").
The operation of the Redemption Facility is entirely at the
discretion of the board of directors of the Company (the
"Board").
The Company announced on 14 October 2024 that
valid redemption requests in respect of 163,834,887 Ordinary Shares
had been received for the Redemption Point of 22 November 2024. The
deadline for the receipt of redemption Requests was 3:00pm on 11
October 2024.
The Redemption Price of the shares to be
redeemed was calculated by reference to the amount generated upon
the realisation of a Redemption Pool, created for the purpose of
funding the redemption using the Redemption Pool method set out in
the Company's articles of association (the "Articles"), pursuant to
which the Company divided its assets and liabilities into two
pools:
(i)
the redemption pool, consisting of cash, assets and liabilities
attributable to the 163,834,887 Ordinary Shares in respect of which
valid redemption requests were made; and
(ii)
all the other cash, assets and liabilities remained attributable to
the continuing shareholders and have continued to be managed in
accordance with the current investment policy.
The assets of the Redemption Pool have now been
realised in full.
The calculated Redemption Price per Ordinary
Share equals the aggregate cash received by the Company upon the
realisation of the Redemption Pool, after deducting the costs of
the redemption, and a pro-rata share of the costs and expenses of
the Company not attributable to a particular pool, divided by the
number of Redemption Shares. The calculated Redemption Price is
154.76 pence per share including dividends and bank interest
received.
As such, 163,834,887 Ordinary Shares will be
redeemed and cancelled by the Company.
Shareholders who validly applied to have their
Ordinary Shares redeemed will receive the Redemption Price per
share. It is expected that despatch of payments in respect of the
valid redemption requests will be made on or around 20 December
2024.
As previously announced, the Board engaged a
third party to undertake sanctions checking in order to satisfy
itself that no beneficial owner appears on the UK Sanctions
Register or other prohibited register as they are required to do in
accordance with UK legislation. A small percentage of shareholders
that have applied to participate in the redemption process have not
responded to multiple contact attempts and will not receive
payment. The Company will continue to withhold payment until such
time as this confirmation is received.
Following this redemption and with effect from
today, the issued share capital of the Company consists of
315,152,309 Ordinary Shares, of which 31,732,318 Ordinary Shares
are held in Treasury. Therefore, the total number of voting rights
in the Company is 283,419,991.
This total voting rights figure may be used by
shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or
a change to their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.
Defined terms
in the announcement have the same meaning as set out in the
Articles of Association, a copy of which may be obtained from the
Company Secretary.
Enquiries:
J.P. Morgan
Cazenove
|
William Simmonds, Rupert Budge
|
Telephone: +44 (0)20 3493 8000
|
|
NSM Funds (UK)
Limited
|
Brian Smith, Ciara McKillop
|
Telephone: +44 (0)20 3697 5770
|
|
H/Advisors
Maitland
|
William Clutterbuck
|
Telephone: +44 (0) 7785 292 617
|
|
Bellevue Asset
Management (UK) Ltd.
|
Mark Ghahramani
|
Telephone: +44 (0)20 3326 2981
|